Disease Info Card

Childhood Brain Neoplasm

Information about Childhood Brain Neoplasm: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Childhood Brain Neoplasm

Most recent studies have shown that Childhood Brain Neoplasm shares some biological mechanisms with astrocytoma, brain-neoplasms, brain-tumor-primary, central-nervous-system-neoplasms, cerebellar-neoplasms, craniopharyngioma, ependymoma, glioblastoma, glioma, malignant-childhood-neoplasm, malignant-neoplasms, malignant-paraganglionic-neoplasm, medulloblastoma, neoplasm-recurrence-local, neoplasms, nervous-system-neoplasms, nervousness, neuroectodermal-tumor-primitive, neuroectodermal-tumors, pilocytic-astrocytoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Childhood Brain Neoplasm, and have been seen in publications frequently: Angiogenesis, Brain Development, Cell Cycle, Cell Death, Cell Differentiation, Cell Growth, Cell Migration, Cell Proliferation, Dna Repair, Drug Resistance, Hormone Secretion, Immune Response, Localization, Methylation, Mitosis, Neurogenesis, Oncogenesis, Pathogenesis, Secretion, Senescence

Quite a number of genes have been found to play important roles in Childhood Brain Neoplasm, such as AKT1, CSF2, EGFR, FAS, GGH, GH1, GLI1, LAMC2, MB, MID1, MYC, MYCN, NDUFB6, OPN1SW, POMT1, PTCH1, SHH, SMARCB1, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.